1. Home
  2. AX vs ALKS Comparison

AX vs ALKS Comparison

Compare AX & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Axos Financial Inc.

AX

Axos Financial Inc.

HOLD

Current Price

$88.75

Market Cap

4.8B

Sector

Finance

ML Signal

HOLD

Logo Alkermes plc

ALKS

Alkermes plc

HOLD

Current Price

$27.94

Market Cap

4.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AX
ALKS
Founded
1999
1987
Country
United States
Ireland
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.8B
4.6B
IPO Year
2005
1991

Fundamental Metrics

Financial Performance
Metric
AX
ALKS
Price
$88.75
$27.94
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
13
Target Price
$97.07
$42.85
AVG Volume (30 Days)
313.8K
1.8M
Earning Date
01-27-2026
10-28-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
2.44
EPS
7.44
2.02
Revenue
$1,202,571,000.00
$1,521,338,000.00
Revenue This Year
$16.70
N/A
Revenue Next Year
$9.76
$24.22
P/E Ratio
$11.88
$13.79
Revenue Growth
6.69
1.08
52 Week Low
$54.46
$25.17
52 Week High
$93.84
$36.45

Technical Indicators

Market Signals
Indicator
AX
ALKS
Relative Strength Index (RSI) 68.40 39.17
Support Level $84.52 $27.53
Resistance Level $87.42 $28.53
Average True Range (ATR) 2.18 0.83
MACD 0.49 -0.08
Stochastic Oscillator 97.63 14.01

Price Performance

Historical Comparison
AX
ALKS

About AX Axos Financial Inc.

Axos Financial Inc is a bank holding company that operates through its bank subsidiary, BofI Federal Bank, a nationwide bank that provides financing for single and multifamily residential properties, small to medium-size businesses in certain sectors, and selected specialty finance receivables. Its operating segments are banking business segment and securities business segment. The bank distributed its products through a wide range of retail distribution channels, including only banking brands, affinity groups, and sales teams, among others. The majority of the bank's mortgage exposure is titled toward the state of California, particularly its southern region. Net interest income is a majority of the bank's revenue.

About ALKS Alkermes plc

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.

Share on Social Networks: